When Canada legalized cannabis in 2018, it carried an explicit moral promise: that those communities most burdened by decades of prohibition would find a place of redress in the new legal economy. A study examining 700 executives and directors across 222 licensed cannabis organizations tells a different story — one in which 84 percent of industry leaders are white and 86 percent are male, a portrait that reflects not the country's diversity, nor its stated intentions, but the familiar consolidation of opportunity among those who already held it. The legal cannabis industry has become, in this
Legal cannabis industry leadership remains overwhelmingly white and male in Canada
The legal cannabis industry remains a space where white men hold overwhelming power
When the government legalized cannabis, did they explicitly say this would help communities that had been harmed by prohibition?
Yes. That was part of the stated rationale. Legalization was framed partly as a justice issue—a way to address the disproportionate enforcement and incarceration that had fallen on Black Canadians, Indigenous peoples, and other marginalized groups.
So what went wrong? Why didn't that happen?
The barriers to entry in the legal market are steep: regulatory costs, startup capital, access to financing. Those obstacles hit hardest for people without existing wealth or networks. And those tend to be the same communities that were most harmed by prohibition.
Is this unique to Canada?
No. The same thing happened in the United States. The legal cannabis market there also concentrated in the hands of white operators, while communities of color were largely locked out. Canada seems to be following the same path.
What would it take to change this?
The research brief doesn't say, but the answer probably involves deliberate intervention—things like preferential licensing, access to capital programs, or regulatory structures designed to lower barriers for entrepreneurs from marginalized communities. Without that, the market will continue to look like it does now.
And if nothing changes?
Then legalization becomes another example of how a system that was supposed to be transformative ended up reproducing the same inequalities it was meant to fix.
O Pulso
- Canada's legal cannabis industry, born from promises of equity and redress, has instead concentrated leadership almost entirely in the hands of white men — a finding so stark it demands more than statistical acknowledgment.
- Black Canadians make up just 1 percent of cannabis industry leadership; Indigenous representation sits at 2 percent, a figure inflated almost entirely by a single Nova Scotia entity — numbers that expose the gap between legalization's rhetoric and its reality.
- The pattern mirrors the American cannabis market, where communities of colour were most heavily policed under prohibition and are now most thoroughly excluded from the legal wealth it generated.
- High startup costs, complex regulatory burdens, and discriminatory barriers to capital have effectively locked out the very entrepreneurs legalization was meant to empower, reproducing the exclusions of the old economy inside the new one.
- Without deliberate structural intervention — in licensing, financing, and ownership policy — researchers warn that Canada is not correcting a historical injustice but simply replicating a mistake already made elsewhere.
When Canada legalized cannabis in 2018, it carried an explicit moral promise: that those communities most burdened by decades of prohibition would find a place of redress in the new legal economy. A study examining 700 executives and directors across 222 licensed cannabis organizations tells a different story — one in which 84 percent of industry leaders are white and 86 percent are male, a portrait that reflects not the country's diversity, nor its stated intentions, but the familiar consolidation of opportunity among those who already held it. The legal cannabis industry has become, in this light, not a corrective to historical injustice but a continuation of it, dressed in the language of reform.
When Canada legalized cannabis in 2018, the stated promise was restorative: an opportunity to redirect wealth and power toward the communities — Black Canadians, Indigenous peoples, and other marginalized groups — who had borne the heaviest costs of prohibition for generations. That promise, a new study suggests, has largely gone unfulfilled.
Researchers at the Centre on Drug Policy Evaluation and the University of Toronto examined 700 executives and directors across 222 licensed cannabis organizations and found a leadership landscape that bears little resemblance to the country it operates in. Eighty-four percent of those leaders are white; 86 percent are male. Among the remaining 16 percent who are not white, representation is thin and scattered — 6 percent South Asian, 3 percent East or Southeast Asian, 2 percent Indigenous, 1 percent Black, 1 percent Latinx. These are not gaps in an otherwise diverse structure. They are the full accounting.
The Indigenous figure of 2 percent is itself misleading: it is heavily skewed by a single entity, the Assembly of Nova Scotia Mi'kmaq Chiefs, which holds a majority stake in one licensed producer. Remove that outlier, and the numbers grow starker still.
The Canadian experience mirrors what has already unfolded in the United States, where the legal cannabis market similarly concentrated ownership among white operators while communities of colour — those most aggressively policed under prohibition — were largely excluded. The barriers are structural and familiar: high startup costs, expensive regulatory compliance, and persistent discrimination in access to banking and capital. For entrepreneurs without existing wealth or connections, entry is difficult. For those from communities historically shut out of lending and investment, it is nearly impossible.
The legal cannabis industry that emerged from reform looks, in the end, like every other extractive industry in Canada — dominated by established money, closed to outsiders, and indifferent to the justice claims that once justified its creation. The communities most harmed by prohibition remain, once again, on the outside looking in.
When Canada legalized cannabis in 2018, the promise was clear: this was a chance to undo decades of harm, to build an industry that would finally include the communities most damaged by prohibition. Black Canadians, Indigenous peoples, and other marginalized groups had borne the weight of enforcement for generations. Legalization was supposed to be different.
Four years in, a detailed accounting suggests that promise has largely evaporated. Researchers at the Centre on Drug Policy Evaluation and the University of Toronto examined the leadership of Canada's legal cannabis industry—700 executives and directors across 222 licensed organizations—and found a landscape that looks nothing like the country it operates in. Eighty-four percent of these leaders are white. Eighty-six percent are male. The numbers are so stark they barely require interpretation: the legal cannabis industry has become a space where white men have consolidated power almost completely.
The disparity extends beyond simple gender and race categories. Among the remaining 16 percent of leaders who are not white, the breakdown is thin and scattered. Six percent are South Asian. Three percent are East or Southeast Asian. Two percent are Indigenous—and even that small figure is heavily skewed by a single entity: the Assembly of Nova Scotia Mi'kmaq Chiefs, which holds a 51 percent stake in the licensed producer AtlantiCann. Two percent are Arab. One percent are Black. One percent are Latinx. These are not rounding errors in a diverse leadership structure. They are the actual representation of entire communities within an industry that was supposed to serve them.
The Canadian pattern mirrors what has already happened in the United States, where the legal cannabis market has similarly concentrated wealth and power among white operators while communities of color—the ones most heavily policed under prohibition—have been largely locked out. The research brief notes this parallel explicitly, suggesting that without deliberate intervention, Canada is simply repeating a mistake already made elsewhere.
What makes this particularly significant is the stated intention behind legalization itself. The federal government framed cannabis reform partly as a justice issue, a way to address the disproportionate harm that drug prohibition had inflicted on Black Canadians, Indigenous peoples, and other marginalized groups. Thousands had been arrested, convicted, and incarcerated under cannabis prohibition. Communities had been destabilized. The legal market was supposed to be a corrective—a way to redirect opportunity and wealth toward those communities.
Instead, the industry that emerged looks like every other extractive industry in Canada: dominated by established money, concentrated in the hands of those who already had access to capital and networks, and largely closed to outsiders. The barriers are familiar: startup costs are high, regulatory compliance is complex and expensive, and access to banking and financing remains difficult. For entrepreneurs without existing wealth or connections, entry is nearly impossible. For entrepreneurs from communities that have historically faced discrimination in lending and business, it is even more so.
The research brief does not offer solutions, but the problem is clear. If legalization was meant to be transformative—to create a more just industry than the one it replaced—then by the measure of who actually leads it, that transformation has not occurred. The legal cannabis industry in Canada remains a space where white men hold the overwhelming majority of power, and where the communities most harmed by prohibition remain, once again, on the outside looking in.
Citações Notáveis
Black and Indigenous people, and women, are vastly underrepresented in leadership positions in the Canadian cannabis industry, when compared to their representation in the general population. Conversely, White men are overrepresented.— Centre on Drug Policy Evaluation policy brief